CANMAT Task Force Recommendations for the Use of Ketamine

<p>Can we use ketamine as a maintenance treatment for MDD?<br /> In this episode, Dr. Phelps discusses CANMAT’s recommendations for the use of ketamine for MDD.</p> <p>Faculty: Jim Phelps, M.D.<br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163"> <strong>Earn 0.5 CMEs: Quick Take Vol. 35</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/the-canadian-network-for-mood-and-anxiety-treatments-canmat-task-force-recommendations-for-the-use-of-racemic-ketamine-in-adults-with-major-depressive-disorder-2632-5169?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC163"> <strong>The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults With Major Depressive Disorder</strong></a></li> </ul>